https://analytical.gmp-compliance.org/ https://analytical.gmp-compliance.org/about.html https://analytical.gmp-compliance.org/news.html https://analytical.gmp-compliance.org/news/news-detail.html https://analytical.gmp-compliance.org/conferences-and-courses.html https://analytical.gmp-compliance.org/all-eca-activities.html https://analytical.gmp-compliance.org/members.html https://analytical.gmp-compliance.org/membership/registration.html https://analytical.gmp-compliance.org/qa.html https://analytical.gmp-compliance.org/about-us-contact.html https://analytical.gmp-compliance.org/imprint.html https://analytical.gmp-compliance.org/privacy-policy.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-from-garbage-bags-with-analytical-records-to-pre-signed-and-backdated-data.html https://analytical.gmp-compliance.org/news/news-detail/reminder-oos-survey-participation-possible-until-8-april.html https://analytical.gmp-compliance.org/news/news-detail/questions-and-answers-on-system-suitability-tests-sst-part-3.html https://analytical.gmp-compliance.org/news/news-detail/statistical-process-control-spc-survey-result-report-now-available.html https://analytical.gmp-compliance.org/news/news-detail/cmdh-ema-new-update-to-appendix-1-on-nitrosamines.html https://analytical.gmp-compliance.org/news/news-detail/edqm-how-should-the-specification-of-a-substance-be-presented-in-a-cep-application.html https://analytical.gmp-compliance.org/news/news-detail/how-is-the-validation-of-analytical-methods-performed.html https://analytical.gmp-compliance.org/news/news-detail/proposal-for-new-usp-chapter-319-on-nmr-block-length-determination.html https://analytical.gmp-compliance.org/news/news-detail/which-gmp-requirements-apply-to-stability-studies-in-the-pharmaceutical-industry.html https://analytical.gmp-compliance.org/news/news-detail/new-usp-stimuli-articles-on-dissolution-testing.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-to-us-manufacturer-highlights-laboratory-deficiencies.html https://analytical.gmp-compliance.org/news/news-detail/process-of-sampling-and-sample-management-in-the-pharmaceutical-industry.html https://analytical.gmp-compliance.org/news/news-detail/ema-reflection-paper-on-non-mutagenic-impurities-published.html https://analytical.gmp-compliance.org/news/news-detail/your-input-is-requested-aqcg-survey-on-oos-investigations.html https://analytical.gmp-compliance.org/news/news-detail/ema-q-a-co-processed-excipients-published.html https://analytical.gmp-compliance.org/news/news-detail/eca-survey-results-ii-how-is-statistical-process-control-used-in-the-pharmaceutical-industry.html https://analytical.gmp-compliance.org/news/news-detail/eurachem-publishes-new-guide-on-the-fitness-for-intended-use-of-analytical-equipment-and-systems.html https://analytical.gmp-compliance.org/news/news-detail/analytical-quality-group-developments-september-through-december-2025.html https://analytical.gmp-compliance.org/news/news-detail/questions-and-answers-on-system-suitability-tests-sst-part-2.html https://analytical.gmp-compliance.org/news/news-detail/ema-stability-data-for-variations-update-to-the-guideline.html https://analytical.gmp-compliance.org/news/news-detail/edqm-new-general-chapter-quality-of-data-available.html https://analytical.gmp-compliance.org/news/news-detail/eca-survey-results-i-how-is-statistical-process-control-used-in-the-pharmaceutical-industry.html https://analytical.gmp-compliance.org/news/news-detail/become-a-speaker-at-pharmalab-2026-analytic-bioanalytic-microbiology.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-oos-handling-and-hplc-method-validation.html https://analytical.gmp-compliance.org/news/news-detail/revised-ph-eur-chapters-2-9-42-and-2-9-43-on-dissolution-testing.html https://analytical.gmp-compliance.org/news/news-detail/korean-mfds-publishes-data-collection-on-dissolution-test-methods.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-1500-oos-results-with-numerous-inadequate-investigations.html https://analytical.gmp-compliance.org/news/news-detail/questions-and-answers-on-system-suitability-tests-sst-part-1.html https://analytical.gmp-compliance.org/news/news-detail/pharmalab-2025-brief-summary-of-aqcg-track-save-the-date-for-2026.html https://analytical.gmp-compliance.org/news/news-detail/fda-form-483-excel-based-data-falsification-and-duplicate-log-books.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-criticises-handling-of-oos-results-at-a-contract-laboratory.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-no-recall-conducted-despite-confirmed-benzene-impurity.html https://analytical.gmp-compliance.org/news/news-detail/cmdh-ema-update-to-appendix-1-for-nitrosamines.html https://analytical.gmp-compliance.org/news/news-detail/ema-cmdh-nitrosamines-q-a-document-updated-again.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-to-u-s-based-otc-manufacturer-deficiencies-in-release-testing-raw-material-controls-and-stability-program.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-highlights-deficiencies-in-sst-and-hplc-practices.html https://analytical.gmp-compliance.org/news/news-detail/proposed-revision-of-usp-1225-published-in-the-pharmacopeial-forum.html https://analytical.gmp-compliance.org/news/news-detail/recent-publications-highlighting-topics-to-be-discussed-at-pharmalab-2025.html https://analytical.gmp-compliance.org/news/news-detail/usp-seeks-early-input-on-new-nmr-method.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-missing-tests-missing-proof.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-missing-stability-testings.html https://analytical.gmp-compliance.org/news/news-detail/mat-survey-by-the-british-nc3rs.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-from-inadequate-investigations-and-laboratory-controls-to-supplier-qualification-and-process-validation.html https://analytical.gmp-compliance.org/news/news-detail/shelf-life-vs-retest-date-whats-the-difference.html https://analytical.gmp-compliance.org/news/news-detail/mean-kinetic-temperature-mkt-calculation-benefits-and-limitations.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-highlights-oos-handling-and-stability-failures.html https://analytical.gmp-compliance.org/news/news-detail/pharmeuropa-revision-of-residual-solvents-chapter-2-4-24-published-for-comments.html https://analytical.gmp-compliance.org/news/news-detail/usp-harmonized-chapter-701-disintegration-adopted.html https://analytical.gmp-compliance.org/news/news-detail/what-is-the-atp.html https://analytical.gmp-compliance.org/news/news-detail/what-is-the-difference-between-bracketing-and-matrixing.html https://analytical.gmp-compliance.org/news/news-detail/usp-nf-stimuli-article-on-apex-vessels-used-in-dissolution-testing-corrected-version-published.html https://analytical.gmp-compliance.org/news/news-detail/analytical-quality-group-developments-may-through-august-2025.html https://analytical.gmp-compliance.org/news/news-detail/meet-the-aqcg-board-members-at-pharmalab-2025.html https://analytical.gmp-compliance.org/news/news-detail/who-is-allowed-to-perform-sampling.html https://analytical.gmp-compliance.org/news/news-detail/who-guidelines-on-reducing-animal-testing.html https://analytical.gmp-compliance.org/news/news-detail/usp-chapters-balances-41-and-weighing-on-an-analytical-balance-1251-final.html https://analytical.gmp-compliance.org/news/news-detail/usp-publishes-revision-of-chapter-111-design-and-analysis-of-biological-assays.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-with-a-diverse-list-of-deficiencies.html https://analytical.gmp-compliance.org/news/news-detail/3r-a-global-approach-with-implications-for-the-pharmaceutical-industry.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-missing-identity-tests-unverified-coas-and-inadequate-deg-eg-controls.html https://analytical.gmp-compliance.org/news/news-detail/usp-responds-to-comments-on-chapter-202-hptlc-identification-of-fixed-oils.html https://analytical.gmp-compliance.org/news/news-detail/ema-hma-nitrosamine-report-published.html https://analytical.gmp-compliance.org/news/news-detail/usp-veroeffentlicht-revision-der-kapitels-111-design-and-analysis-of-biological-assays.html https://analytical.gmp-compliance.org/news/news-detail/fda-issues-warning-letter-to-contract-testing-laboratory-for-inadequate-oos-investigations.html https://analytical.gmp-compliance.org/news/news-detail/usp-publishes-comments-rereived-on-chapter-317.html https://analytical.gmp-compliance.org/news/news-detail/ema-publishes-overview-of-comments-received-on-ich-m13b-guideline-on-bioequivalence.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-company-voluntarily-ceases-drug-production.html https://analytical.gmp-compliance.org/news/news-detail/who-trs-1060-nitrosamine-guideline-published.html https://analytical.gmp-compliance.org/news/news-detail/new-hptlc-chapter-proposed-for-the-international-pharmacopoeia.html https://analytical.gmp-compliance.org/news/news-detail/analytical-quality-group-developments-january-through-april-2025.html https://analytical.gmp-compliance.org/news/news-detail/ich-publishes-training-materials-on-q2r2-and-q14.html https://analytical.gmp-compliance.org/news/news-detail/free-webinar-on-sampling-and-sample-management-recording-q-a-document.html https://analytical.gmp-compliance.org/news/news-detail/aqcg-welcomes-two-new-board-members.html https://analytical.gmp-compliance.org/news/news-detail/aqcg-organises-one-day-track-at-pharmalab-2025.html https://analytical.gmp-compliance.org/news/news-detail/inadequate-sampling-and-component-testing-highlighted-in-fda-warning-letter.html https://analytical.gmp-compliance.org/news/news-detail/ema-publishes-new-product-specific-bioequivalence-guidance.html https://analytical.gmp-compliance.org/news/news-detail/revision-of-usp-chapter-1039-chemometrics-published-for-comments.html https://analytical.gmp-compliance.org/news/news-detail/proposal-for-new-usp-chapter-318-nmr-monomer-ratio-determination-for-lactide-glycolide-polymers.html https://analytical.gmp-compliance.org/news/news-detail/new-usp-chapter-1221-on-ongoing-procedure-performance-verification-oppv-published-for-comment.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-missing-testing-no-stability-data-and-inadequate-raw-material-controls.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-memory-based-manufacturing-and-lack-of-analytical-testing.html https://analytical.gmp-compliance.org/news/news-detail/usp-comments-possible-on-the-topic-process-analytical-technology.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-highlights-analytical-deficiencies-lack-of-release-testing-and-unsupported-expiry-dates.html https://analytical.gmp-compliance.org/news/news-detail/ema-cmdh-nitrosamine-q-a-document-updated.html https://analytical.gmp-compliance.org/news/news-detail/usp-informs-about-monographs-affected-by-the-revision-of-nmr-chapters-761-and-1761.html https://analytical.gmp-compliance.org/news/news-detail/apic-update-of-the-nitrosamine-guide.html https://analytical.gmp-compliance.org/news/news-detail/ich-new-guideline-for-stabilities.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-for-chinese-manufacturer-inadequate-testing-and-stability-program-deficiencies.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-missing-testing-for-toxic-impurities-and-lack-of-stability-data-in-otc-drug-products.html https://analytical.gmp-compliance.org/news/news-detail/proposal-for-usp-chapter-320-nmr-based-determination-of-degree-of-hydrolysis-and-monomer-ratio-in-polyvinyl-alcohols.html https://analytical.gmp-compliance.org/news/news-detail/new-ich-q1-draft-guideline-whats-changing-in-stability-testing.html https://analytical.gmp-compliance.org/news/news-detail/new-eca-guidance-on-sampling-and-sample-management.html https://analytical.gmp-compliance.org/news/news-detail/update-of-usp-chapter-1099-on-content-uniformity-in-large-samples.html https://analytical.gmp-compliance.org/news/news-detail/usp-education-webinar-on-1058.html https://analytical.gmp-compliance.org/news/news-detail/ema-publishes-draft-of-ich-m13b-guideline-on-bioequivalence.html https://analytical.gmp-compliance.org/news/news-detail/public-consultation-on-ich-m13b-guideline-on-bioequivalence-launched-in-switzerland.html https://analytical.gmp-compliance.org/news/news-detail/biophorum-publishes-guidance-for-ich-q2r2-and-q14-implementation.html https://analytical.gmp-compliance.org/news/news-detail/mhra-class-2-recall-due-to-blister-pack-mislabeling.html https://analytical.gmp-compliance.org/news/news-detail/otc-drug-production-ceased-after-fda-warning-letter.html https://analytical.gmp-compliance.org/news/news-detail/ema-publishes-four-new-product-specific-bioequivalence-guidance.html https://analytical.gmp-compliance.org/news/news-detail/pharmeuropa-new-chapter-on-evaporative-light-scattering-detection-published-for-comment.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-missing-ongoing-stability-program-for-biotech-apis.html https://analytical.gmp-compliance.org/news/news-detail/pharmeuropa-four-draft-chapters-on-elemental-analysis-published-for-comment.html https://analytical.gmp-compliance.org/news/news-detail/missing-tests-and-altered-records-fda-warns-chinese-otc-manufacturer.html https://analytical.gmp-compliance.org/news/news-detail/become-a-speaker-at-pharmalab-2025-analytics-bioanalytics-microbiology-and-more.html https://analytical.gmp-compliance.org/news/news-detail/inadequate-dissolution-testing-and-process-validation-trigger-fda-warning-letter.html https://analytical.gmp-compliance.org/news/news-detail/who-update-of-guideline-of-reference-standards.html https://analytical.gmp-compliance.org/news/news-detail/fda-issues-warning-letter-due-to-gmp-violations-at-chinese-drug-manufacturer.html https://analytical.gmp-compliance.org/news/news-detail/cmdh-ema-appendix-1-for-nitrosamines-revised.html https://analytical.gmp-compliance.org/news/news-detail/usp-nf-stimuli-article-on-analysis-of-residual-solvents.html https://analytical.gmp-compliance.org/news/news-detail/ema-publishes-considerations-regarding-the-implementation-of-ich-m13a-on-bioequivalence.html https://analytical.gmp-compliance.org/news/news-detail/further-modifications-to-usp-chapter-621-chromatography-published-for-comment.html https://analytical.gmp-compliance.org/news/news-detail/who-updates-on-method-transfer.html https://analytical.gmp-compliance.org/news/news-detail/proposed-update-to-usp-1058-on-analytical-instrument-and-system-qualification.html https://analytical.gmp-compliance.org/news/news-detail/illegally-imported-medicinal-products-into-switzerland-in-2024-fewer-shipments-but-increasing-risks.html https://analytical.gmp-compliance.org/news/news-detail/eurachem-publishes-leaflet-on-analytical-equipment-and-systems.html https://analytical.gmp-compliance.org/news/news-detail/ema-q-a-when-is-testing-for-endotoxin-masking-effects-necessary-for-biological-products.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-highlights-responsibilities-of-contract-testing-laboratories.html https://analytical.gmp-compliance.org/news/news-detail/new-iso-tr-334022025-on-reference-material-preparation.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-chinese-api-manufacturer-on-import-alert-due-to-cgmp-violations.html https://analytical.gmp-compliance.org/news/news-detail/warning-letter-caused-by-incomplete-impurity-profiles.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-for-chinese-contract-testing-laboratory.html https://analytical.gmp-compliance.org/news/news-detail/usp-announces-corrections-to-general-chapter-1132-1-on-residual-host-cell-protein-measurement.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-focus-on-quality-control-of-apis-and-excipients.html https://analytical.gmp-compliance.org/news/news-detail/us-fda-carcinogenic-potency-categorization-approach-for-nitrosamine-impurities.html https://analytical.gmp-compliance.org/news/news-detail/revision-of-usp-1032-design-and-development-of-biological-assays.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-to-chinese-manufacturer-of-otc-products.html https://analytical.gmp-compliance.org/news/news-detail/warning-letter-no-testing-for-ec-deg-and-other-deficiencies.html https://analytical.gmp-compliance.org/news/news-detail/english-translation-of-supplement-ii-to-the-japanese-pharmacopoeia-jp18-published.html https://analytical.gmp-compliance.org/news/news-detail/pharmalab-2024-brief-summary-save-the-date-for-2025.html https://analytical.gmp-compliance.org/news/news-detail/how-to-keep-analytical-systems-current-and-compliant.html https://analytical.gmp-compliance.org/news/news-detail/fda-483s-due-to-deficiencies-in-the-stability-program-evaluation-of-fiscal-year-2024.html https://analytical.gmp-compliance.org/news/news-detail/usp-nf-stimuli-article-on-apex-vessels-used-in-dissolution-testing.html https://analytical.gmp-compliance.org/news/news-detail/elemental-impurities-harmonized-chapter-finalized.html https://analytical.gmp-compliance.org/news/news-detail/new-fda-guidelines-batch-uniformity-and-drug-product-integrity-advanced-manufacturing-technologies.html https://analytical.gmp-compliance.org/news/news-detail/data-integrity-violations-and-ineffective-quality-systems.html https://analytical.gmp-compliance.org/news/news-detail/edqm-publishes-new-faq-on-system-suitability-test-sst.html https://analytical.gmp-compliance.org/news/news-detail/cmdh-ema-update-of-appendix-1-for-nitrosamines.html https://analytical.gmp-compliance.org/news/news-detail/another-fda-warning-letter-based-on-review-of-records.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-to-south-african-otc-drug-manufacturer.html https://analytical.gmp-compliance.org/news/news-detail/fda-inspections-in-the-eu-warning-letter-to-italian-otc-drug-manufacturer.html https://analytical.gmp-compliance.org/news/news-detail/the-interplay-of-data-governance-integrity-and-quality-in-pharmaceutical-analysis.html https://analytical.gmp-compliance.org/news/news-detail/new-gmp-journal-article-on-analytical-instrument-qualification-and-system-validation.html https://analytical.gmp-compliance.org/news/news-detail/fda-warns-chinese-otc-drug-manufacturer-following-review-of-records.html https://analytical.gmp-compliance.org/news/news-detail/usp-nf-stimuli-article-on-stability-of-compounded-preparations.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-pest-activity-water-leaks-and-misuse-of-qc-laboratory-in-u-s-drug-manufacturing-facility.html https://analytical.gmp-compliance.org/news/news-detail/edqm-publishes-new-chapter-quality-of-data-for-comments.html https://analytical.gmp-compliance.org/news/news-detail/us-fda-warning-letter-lab-data-integrity-issues.html https://analytical.gmp-compliance.org/news/news-detail/management-circumvents-quality-department-in-deviation-classification-fda-warning-letter.html https://analytical.gmp-compliance.org/news/news-detail/ec-new-requirements-for-pfas-subgroup-adopted.html https://analytical.gmp-compliance.org/news/news-detail/us-fda-warning-letter-testing-of-incoming-goods.html https://analytical.gmp-compliance.org/news/news-detail/host-cell-proteins-fda-seeks-comments-on-immunogenicity-assessment.html https://analytical.gmp-compliance.org/news/news-detail/fda-updated-guidance-for-nitrosamines.html https://analytical.gmp-compliance.org/news/news-detail/usp-commenting-on-balances-41-and-weighing-on-an-analytical-balance-1251-possible-again.html https://analytical.gmp-compliance.org/news/news-detail/meet-the-aqcg-board-members-at-pharmalab-2024.html https://analytical.gmp-compliance.org/news/news-detail/revision-of-usp-chapter-1033-on-validation-of-biological-assays-published.html https://analytical.gmp-compliance.org/news/news-detail/q-as-from-the-live-online-training-introduction-to-the-aqcgs-new-aiqsv-guide-part-2.html https://analytical.gmp-compliance.org/news/news-detail/bioactivity-testing-for-atmps.html https://analytical.gmp-compliance.org/news/news-detail/ema-cmdh-q-a-document-nitrosamines-revised.html https://analytical.gmp-compliance.org/news/news-detail/edqm-availability-of-reference-substances.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-inadequate-lab-testing-procedures.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-to-a-manufacturer-of-an-athlete-muscle-maintenance-creme.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-missing-incoming-control-tests.html https://analytical.gmp-compliance.org/news/news-detail/cmdh-ema-appendix-1-for-nitrosamines-updated-again.html https://analytical.gmp-compliance.org/news/news-detail/ema-cmdh-update-of-appendix-1-for-nitrosamines.html https://analytical.gmp-compliance.org/news/news-detail/ich-q3c-new-version-of-the-guideline-for-residual-solvents-published.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-to-contract-testing-laboratory-in-uruguay-due-to-data-integrity-violations.html https://analytical.gmp-compliance.org/news/news-detail/european-pharmaceutical-review-article-on-ich-q2r2.html https://analytical.gmp-compliance.org/news/news-detail/q-as-from-the-live-online-training-introduction-to-the-aqcgs-new-aiqsv-guide-part-1.html https://analytical.gmp-compliance.org/news/news-detail/usp-11-reference-standards-draft-published-for-comment.html https://analytical.gmp-compliance.org/news/news-detail/further-warning-letter-with-multiple-deviations-to-a-korean-company.html https://analytical.gmp-compliance.org/news/news-detail/usp-responses-to-instrument-qualification-stimuli-published-for-comment.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-missing-identification-tests.html https://analytical.gmp-compliance.org/news/news-detail/fda-form-483-lists-10-observations-made-during-an-inspection-of-an-indian-drug-manufacturer.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-missing-ongoing-stability-studies-for-apis.html https://analytical.gmp-compliance.org/news/news-detail/usp-plans-new-chapter-on-process-analytical-technology-pat.html https://analytical.gmp-compliance.org/news/news-detail/the-new-aqcg-eca-aiqsv-guide-download-training-comments.html https://analytical.gmp-compliance.org/news/news-detail/ema-cmdh-appendix-1-for-nitrosamines-updated-again.html https://analytical.gmp-compliance.org/news/news-detail/edqm-top-ten-deficiencies-for-ceps.html https://analytical.gmp-compliance.org/news/news-detail/swissmedic-nitrosamine-requirements-updated.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-observed-particulates-in-repackaged-drug-components.html https://analytical.gmp-compliance.org/news/news-detail/edqm-addendum-11-5-to-the-european-pharmacopoeia-available.html https://analytical.gmp-compliance.org/news/news-detail/ema-cmdh-nitrosamine-q-a-document-revised.html https://analytical.gmp-compliance.org/news/news-detail/edqm-overview-of-reference-substances-updated.html https://analytical.gmp-compliance.org/news/news-detail/edqm-comments-on-the-nitrosamine-monograph-possible.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-testing-of-incoming-goods.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-missing-stability-studies.html https://analytical.gmp-compliance.org/news/news-detail/fda-form-483-calibration-of-analytical-instruments.html https://analytical.gmp-compliance.org/news/news-detail/the-new-eca-guide-on-analytical-instrument-qualification-and-system-validation-aiqsv.html https://analytical.gmp-compliance.org/news/news-detail/ich-guidelines-q2r2-validation-of-analytical-procedures-and-ich-q14-analytical-procedure-development-published.html https://analytical.gmp-compliance.org/news/news-detail/outcome-of-the-aqcg-board-meeting-in-november-new-board-member-and-approval-of-the-aiqsv-guide.html https://analytical.gmp-compliance.org/news/news-detail/fda-483s-due-to-deficiencies-in-the-stability-program-evaluation-of-fiscal-year-2023.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-lack-of-identity-testing-and-stability-program.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-inadequate-quality-systems.html https://analytical.gmp-compliance.org/news/news-detail/new-editon-of-iupac-compendium-of-terminology-in-analytical-chemistry.html https://analytical.gmp-compliance.org/news/news-detail/eca-analytical-quality-control-group-nominates-new-board-member.html https://analytical.gmp-compliance.org/news/news-detail/usp-chapter-621-chromatography-published-for-comments.html https://analytical.gmp-compliance.org/news/news-detail/ema-revises-guidance-on-development-production-characterization-and-specification-for-monoclonal-antibodies-and-related-products.html https://analytical.gmp-compliance.org/news/news-detail/usp-briefing-on-mass-spectrometry-based-multi-attribute-method-for-therapeutic-proteins.html https://analytical.gmp-compliance.org/news/news-detail/usp-excipient-stimuli-published-for-comments.html https://analytical.gmp-compliance.org/news/news-detail/usp-chapter-weighing-on-an-analytical-balance-1251-published-for-comments.html https://analytical.gmp-compliance.org/news/news-detail/new-ema-reflection-paper-on-the-use-of-artificial-intelligence.html https://analytical.gmp-compliance.org/news/news-detail/usp-comments-possible-on-the-topic-balances-41.html https://analytical.gmp-compliance.org/news/news-detail/edqm-excipient-monographs.html https://analytical.gmp-compliance.org/news/news-detail/usp-chapter-2-oral-drug-products-product-quality-tests-published-for-comments.html https://analytical.gmp-compliance.org/news/news-detail/apic-ich-m7-how-to-do-document-published.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-inadequate-api-testing.html https://analytical.gmp-compliance.org/news/news-detail/usp-third-instrument-qualification-stimuli-published-for-comments.html https://analytical.gmp-compliance.org/news/news-detail/cmc-fda-publishes-guideline-with-questions-on-post-approval-modification-of-single-use-materials.html https://analytical.gmp-compliance.org/news/news-detail/ich-guidance-q14-q2r2-analytical-method-development-method-validation-published-for-consultation.html https://analytical.gmp-compliance.org/news/news-detail/usp-second-stimuli-article-on-instrument-qualification-published-for-comments.html https://analytical.gmp-compliance.org/news/news-detail/who-publishes-guidance-on-safe-production-and-quality-control-of-monoclonal-antibodies.html https://analytical.gmp-compliance.org/news/news-detail/analytical-procedure-life-cycle-new-usp-chapter-1220-published.html https://analytical.gmp-compliance.org/news/news-detail/new-fda-draft-guidance-microbiological-quality-control-of-non-sterile-medicinal-products.html https://analytical.gmp-compliance.org/news/news-detail/warning-letter-regarding-insufficiencies-around-access-control.html https://analytical.gmp-compliance.org/news/news-detail/cov19-vaccine-mix-up-in-the-us-whats-behind-it.html https://analytical.gmp-compliance.org/news/news-detail/uk-recognition-of-eu-eea-batch-testing-does-not-end-on-1-january-2023.html https://analytical.gmp-compliance.org/news/news-detail/a-lifecycle-approach-for-analytical-instrument-and-systems-qualification.html https://analytical.gmp-compliance.org/news/news-detail/from-valsartan-to-ranitidine-nitrosamine-impurities-and-the-measures-taken-by-the-ema-and-the-edqm.html https://analytical.gmp-compliance.org/news/news-detail/fda-publishes-q-a-on-internal-standard-responses-in-chromatography-bioanalysis.html https://analytical.gmp-compliance.org/news/news-detail/brexit-industry-should-keep-timelines-for-batch-testing-facilities.html https://analytical.gmp-compliance.org/news/news-detail/is-an-identity-test-needed-for-the-content-of-all-containers.html https://analytical.gmp-compliance.org/news/news-detail/data-integrity-still-in-the-focus-of-fda-new-warning-letter-to-japanese-api-manufacturer.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-due-to-non-compliance-with-specifications-and-testing.html https://analytical.gmp-compliance.org/news/news-detail/lack-of-oos-investigation-leads-to-fda-warning-letter.html https://analytical.gmp-compliance.org/news/news-detail/must-each-container-of-a-starting-material-be-sampled-for-identification.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-due-to-not-functioning-hplc-audit-trail.html https://analytical.gmp-compliance.org/news/news-detail/quality-risk-management-what-inspectors-are-looking-for.html https://analytical.gmp-compliance.org/news/news-detail/can-the-8730n1-rule-be-accepted-in-sampling-plans.html https://analytical.gmp-compliance.org/news/news-detail/eca-data-integrity-task-force-issues-version-2-0-of-data-integrity-guide.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-due-to-faulty-sampling.html https://analytical.gmp-compliance.org/news/news-detail/measurement-uncertainty-for-the-pharmaceutical-industry.html https://analytical.gmp-compliance.org/news/news-detail/warning-letter-due-to-non-compliance-with-specifications.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-due-to-non-compliance-with-specifications.html https://analytical.gmp-compliance.org/news/news-detail/specifications-and-acceptance-criteria-for-impurities-new-fda-principles.html https://analytical.gmp-compliance.org/news/news-detail/usp-stimuli-article-proceedings-of-the-analytical-lifecycle-workshop-2016.html https://analytical.gmp-compliance.org/news/news-detail/revision-of-the-usp-chapter-on-raman.html https://analytical.gmp-compliance.org/news/news-detail/eu-inspection-complaints-due-to-inadequate-handling-of-oos-results.html https://analytical.gmp-compliance.org/news/news-detail/analytical-procedure-lifecycle-management-guidance-for-all-participants-of-the-aplm-conference.html https://analytical.gmp-compliance.org/news/news-detail/comprehensive-document-about-the-handling-of-ooe-and-oot-results.html https://analytical.gmp-compliance.org/news/news-detail/how-to-prepare-for-a-data-integrity-inspection.html https://analytical.gmp-compliance.org/news/news-detail/missing-oos-trending-leads-to-fda-warning-letter.html https://analytical.gmp-compliance.org/news/news-detail/heparin-in-the-fdas-focus-once-more-warning-letter-for-chinese-contract-lab.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-due-to-incorrect-sampling.html https://analytical.gmp-compliance.org/news/news-detail/fda-warning-letter-due-to-incorrect-certificates-of-analysis.html https://analytical.gmp-compliance.org/news/news-detail/emas-new-guideline-on-the-implementation-of-the-ich-q3d-guideline-in-the-eu.html https://analytical.gmp-compliance.org/news/news-detail/recognition-of-alternative-compendia-bp-ep-jp-by-the-fda.html https://analytical.gmp-compliance.org/news/news-detail/gmp-requirements-for-certificates-of-analysis-coa.html https://analytical.gmp-compliance.org/news/news-detail/proposed-revision-of-the-usp-chapter-on-spectroscopic-methods.html https://analytical.gmp-compliance.org/news/news-detail/revised-usp-chapter-1225-validation-of-compendial-methods-approved.html https://analytical.gmp-compliance.org/news/news-detail/elemental-impurities-the-next-steps-for-the-implementation-of-ich-q3d-into-the-european-pharmacopoeia.html https://analytical.gmp-compliance.org/news/news-detail/revised-usp-chapter-1058-on-analytical-instrument-qualification.html https://analytical.gmp-compliance.org/news/news-detail/new-fda-warning-letter-for-wockhardt-ltd-in-india.html https://analytical.gmp-compliance.org/news/news-detail/opportunities-for-reducing-sampling-and-testing-of-starting-materials.html https://analytical.gmp-compliance.org/news/news-detail/fda-guideline-on-dissolution-testing.html https://analytical.gmp-compliance.org/news/news-detail/consequences-of-the-new-mhra-guideline-for-excel.html https://analytical.gmp-compliance.org/news/news-detail/in-process-revision-to-usp-1058-analytical-instrument-qualification-aiq.html https://analytical.gmp-compliance.org/news/news-detail/ema-nir-guideline-finalised.html https://analytical.gmp-compliance.org/news/news-detail/ema-publishes-document-on-the-validation-of-analytical-methods.html https://analytical.gmp-compliance.org/news/news-detail/dissolution-testing-requirements-of-the-chinese-pharmacopoeia.html https://analytical.gmp-compliance.org/news/news-detail/revision-of-the-usp-chapter-on-spectroscopic-methods.html https://analytical.gmp-compliance.org/news/news-detail/dissolution-testing-planned-revision-of-the-usp-chapter.html https://analytical.gmp-compliance.org/news/news-detail/combined-risk-assessment-for-analytical-instruments-and-computer-systems-in-the-laboratory.html https://analytical.gmp-compliance.org/news/news-detail/analytical-methods-usps-future-expectations.html https://analytical.gmp-compliance.org/news/news-detail/balances-correction-of-the-requirements-in-the-u-s-pharmacopoeia-usp.html https://analytical.gmp-compliance.org/news/news-detail/revision-of-the-usp-general-notices-for-usp-37-nf-32.html https://analytical.gmp-compliance.org/news/news-detail/system-suitability-for-usp-methods-usps-future-expectations.html https://analytical.gmp-compliance.org/news/news-detail/japanese-pharmacopoeia-and-japanese-gmp-regulations-available-online.html https://analytical.gmp-compliance.org/news/news-detail/failures-in-handling-oos-results-cited-in-fda-warning-letters-2013.html